GL Pharm Tech Corp

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

22.99%

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Jeong Wuk Goh

Internal Auditor

Dae Jong Park

Internal Auditor · since 2019

Sang Hyeon Bae

Director

Myeong Ho Jeon

Director

Seong Pil Jin

Co-Chief Executive Officer, Director · since 2024

Yong Yil Kim

Co-Chief Executive Officer, Director · since 2024

Non-Executive Independent Director

URL

IPO date

Nov 20, 2014

Employees

Domiciled in

Incorporated in

No data to show